TrialBlood2019

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.

Jong Wook Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.